Abstract:Lung cancer stands as one of the most prevalent malignancies worldwide, bearing the highest morbidity and mortality rates among all malignant tumors. The treatment of lung cancer primarily encompasses surgical procedures, radiotherapy, and chemotherapy, which are fraught with significant side effects, unfavorable prognoses, and a heightened risk of metastasis and relapse. Although targeted therapy and immunotherapy have gradually gained prominence in lung cancer treatment, diversifying the array of available methods, the overall recovery and survival rates for lung cancer patients remain suboptimal. Presently, with a holistic approach and a focus on syndrome differentiation and treatment, Traditional Chinese Medicine (TCM) has emerged as a pivotal player in the prognosis of cancer patients. TCM possesses characteristics such as targeting multiple aspects, addressing a wide range of concerns, and minimizing toxic side effects. Research demonstrates that Traditional Chinese Medicine can significantly contribute to the treatment or serve as an adjunct to chemotherapy for lung cancer and other lung-related diseases. This is achieved through mechanisms like inhibiting tumor cell proliferation, inducing tumor cell apoptosis, suppressing tumor angiogenesis, influencing the cellular microenvironment, regulating immune system function, impacting signal transduction pathways, and reversing multidrug resistance in tumor cells. In this article, we offer an overview of the advancements in research concerning Traditional Chinese Medicine extracts for the treatment or adjunctive chemotherapy of lung cancer and other lung-related conditions. Furthermore, we delve into the challenges that Traditional Chinese Medicine extracts face in lung cancer treatment, laying the foundation for the development of diagnostic, prognostic, and therapeutic targets.

Sensitization Strategies in Lung Cancer.

Strategies to sensitize cancer cells to immunotherapy

Advances In Combination Of Antiangiogenic Agents Targeting Vegf-Binding And Conventional Chemotherapy And Radiation For Cancer Treatment

Evaluation of the in Vitro Chemosensitivity and Correlation with Clinical Outcomes in Lung Cancer Using the ATP-TCA.

Nano-Assisted Radiotherapy Strategies: New Opportunities for Treatment of Non-Small Cell Lung Cancer

Research Progress in the Use of Combinations of Platinum-Based Chemotherapy and Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors

The role of immunotherapy sensitizers and novel immunotherapy modalities in the treatment of cancer

Combination Strategies of Immunotherapy in Non-Small Cell Lung Cancer: Facts and Challenges

The mechanism and application of traditional Chinese medicine extracts in the treatment of lung cancer and other lung-related diseases

Nanomedicine in Lung Cancer: Current States of Overcoming Drug Resistance and Improving Cancer Immunotherapy

Application of nano-radiosensitizers in non-small cell lung cancer

Nanotechnology: A New Strategy for Lung Cancer Treatment Targeting Pro-Tumor Neutrophils

Cutting-Edge Therapies for Lung Cancer

Advancements in radiotherapy for lung cancer in China

Study on the sensitivity of primary tumor cells of patients with cervical cancer to chemotherapeutic combinations

Strategies to Target Chemoradiotherapy Resistance in Small Cell Lung Cancer

Targeted therapy of non-small cell lung cancer: mechanisms and clinical trials

Understanding the treatment response and resistance to targeted therapies in non-small cell lung cancer: clinical insights and perspectives

Therapeutic advances in non‐small cell lung cancer: Focus on clinical development of targeted therapy and immunotherapy

Moving beyond traditional therapies: the role of nanomedicines in lung cancer

Progress of clinical research on targeted therapy combined with thoracic radiotherapy for non-small-cell lung cancer.